Search research articles
Contact Us
Filters
Showing results (101-110 of 766) with videos related to
Page
of 77
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier
Naoto T Ueno, Elizabeth J Shpall, Richard E Champlin, et al.
Bone Marrow Transplantation
|
November 7, 2002
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development
P Anderlini, F A Chan, R E Champlin, et al.
Cancer
|
November 25, 2003
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses
Hillary H Wu, Moshe Talpaz, Richard E Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection
Qaiser Bashir, Lauren A Langford, Simrit Parmar, et al.
Nature Clinical Practice. Oncology
|
February 1, 2008
Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers
Kazutaka Nakayama, Andrea Milbourne, Leslie R Schover, et al.
Gynecologic Oncology
|
January 31, 2004
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report
Michele L Donato, Charles Levenback, David M Gershenson, et al.
The Oncologist
|
January 28, 2012
Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients
Yee Chung Cheng, Mariko Takagi, Andrea Milbourne, et al.
Biochemical Pharmacology
|
October 12, 2010
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
Benigno C Valdez, Yang Li, David Murray, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 1, 2004
Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation
Paolo Anderlini, Sheetal Sheth, Krystal Hicks, et al.
British Journal of Haematology
|
October 29, 2000
Allogeneic haematopoietic transplantation for Richter's syndrome
J Rodriguez, M J Keating, S O'Brien, et al.
Page
of 77
Search research articles
Search
Showing results (101-110 of 766) with videos related to
Sort By:
Page
of 77
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier
Naoto T Ueno, Elizabeth J Shpall, Richard E Champlin, et al.
Bone Marrow Transplantation
|
November 7, 2002
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development
P Anderlini, F A Chan, R E Champlin, et al.
Cancer
|
November 25, 2003
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses
Hillary H Wu, Moshe Talpaz, Richard E Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection
Qaiser Bashir, Lauren A Langford, Simrit Parmar, et al.
Nature Clinical Practice. Oncology
|
February 1, 2008
Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers
Kazutaka Nakayama, Andrea Milbourne, Leslie R Schover, et al.
Gynecologic Oncology
|
January 31, 2004
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report
Michele L Donato, Charles Levenback, David M Gershenson, et al.
The Oncologist
|
January 28, 2012
Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients
Yee Chung Cheng, Mariko Takagi, Andrea Milbourne, et al.
Biochemical Pharmacology
|
October 12, 2010
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
Benigno C Valdez, Yang Li, David Murray, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 1, 2004
Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation
Paolo Anderlini, Sheetal Sheth, Krystal Hicks, et al.
British Journal of Haematology
|
October 29, 2000
Allogeneic haematopoietic transplantation for Richter's syndrome
J Rodriguez, M J Keating, S O'Brien, et al.
Page
of 77